mastercohort.it

 1. Suter F., Orani A.M., Andreoni A. et al.  Antiretroviral therapy in experienced in real life: the italian MASTER-1 study. In: Proceedings of: “39th Interscience Conference on Antimicrobial Agents and Chemotherapy”. San Francisco (USA), Sept 26-29, 1999; abs 2185.

2. Carosi G., Suter F., Orani A.M. et al.  Surrogate markers in naive HIV patients do not correlate with short term clinical progression in real life: the italian MASTER-1 study. In: Proceedings of: “39th Interscience Conference on Antimicrobial Agents and Chemotherapy”. San Francisco (USA), Sept 26-29, 1999; abs 2191.

3. Mazzotta F., Lo Caputo S., Scudeller L., Torti C., Castelli F., Carosi G. Real-vs-virtual phenotype: 16 week results of a multicentre randomized trial. 1st IAS Conference on HIV Pathogenesis and Treatment, Buenos Aires 2001; abs574.

4. Mazzotta F., Lo Caputo S., Torti C., Tinelli C., Castelli F., Pierotti P., Angarano G., Sighinolfi L., Poggio A., Gianotti N., Maserati R., DeGennaro M., Vivarelli A., DelleFoglie P., Carosi G. Real vs VirtualPhenotype: 12-month results from the GenPherex study. 9th Conference on Retroviruses and Opportunistic Infections. Seattle 2002. Abs 589-T.

5. Torti C., Quiros-Roldan E., Boucher C.A.B., Tinelli C., Been-Tiktak A.M.M., Lo Caputo S., Mazzotta F., Castelli F., Tomasoni L., Day S., Carosi G. Head-to-head comparison of widely used HIV-1 drug resistance algorithms: RetroGram and VGI-Trugene HIV-1. 9th Conference on Retroviruses and Opportunistic Infections. Seattle 2002. Abs 590-T.

6. Pan A., Paraninfo G., Castelli F., et al.  The Italian MASTER cohort – General analysis of antiretroviral therapy in 3580 patients. XIV International AIDS Conference. Barcelona 2002. Abs MoPeB3212.

7. Torti C., Tirelli V., Quiros-Roldan E., Scudeller L., Lo Caputo S., Moretti F., Mazzotta F., Carosi G. Extensive analysis of substitutions in HIV-1 reverse transcriptase gene from a cohort of heavily pretreated patients. 9th European AIDS Conference. Warsaw 2003. Abs 3.4/2.

8. Torti C., Moretti F., Quiros-Roldan E., Tirelli V., Paraninfo G., Lo Caputo S., Mazzotta F., Carosi G. Analisi estensiva delle mutazioni del gene della trascrittasi inversa in una coorte di pazienti fortemente trattati. XII Convegno Nazionale ANLAIDS. Roma 2003. Abs p 118.

9. Lo Caputo S., Trabattoni D., Torti C., Buccoliero G., Pienotti P., Vivarelli A., De Gennaro M., Gianotti N., Mazzotta F., Clerici M. Immunologic analyses in multidrug-experienced HIV-infected individuals upon therapy switch: the Immunogenpherex study. In: Proceedings of: “44th Interscience Conference on Antimicrobial Agents and Chemotherapy”. Washington (USA), Oct 30-Nov 2, 2004; abs H-578.

10. Torti C., Quiros-Roldan E., Regazzi M., De Luca A., Mazzotta F., Carosi G. Salvage HAART guided by rules-based or phenotype-based HIV-1 genotype interpretation with or without TDM: the RADAR trial. In: Program and abstract of the: 7th International Congress on Drug Therapy in HIV Infection. Glasgow, UK, 14-18 November 2004.

11. Torti C., Paraninfo G., Maggiolo F., Patroni A., Ladisa N., Castelnuovo F., Rizzardini G., Orani A., Ghinelli F., Casari S., Carosi G., for the MASTER data-base. Has potency of current HAART reached a plateau: results of the MASTER collaboration. In: Program and abstract of the: 7th International Congress on Drug Therapy in HIV Infection. Glasgow, UK, 14-18 November 2004.

12. Torti C., Quiros-Roldan E., Regazzi M., De Luca A., Mazzotta F., Lo Caputo S., Ladina N., Maggi P., Cargnel A., Micheli V., Orani A., Perini P., Patroni A., Villani P., Moretti F., Di Giambenedetto S., Castelnuovo F., Sterrantino G., Antinori A., Santoro D., Filice G., Sighinolfi L., Carosi G., RADAR-MASTER Study Group. Regimi di salvataggio scelti tramite test di resistenza genotipico di HIV-1 interpretato mediante regole –versus- fenotipo virtuale con o senza intervento di concentrazione farmacologia controllata: lo studio RADAR (Resistance and dosage adapted regimens). XVII Convegno Nazionale AIDS e Sindromi Correlate. Milano, Italy, 28-30 November 2004. Abstract O28.

13. Torti C., Lapadula G., Casari S., Puoti M., Cadeo G.P., Bella D., Pastore G., Ladina N., Minoli L., Sotgiu G., Mazzotta F., Lo Caputo S., Filice C., Zocchetti C., Di Perri G., Bonora S., Chiodo F., Borderi M., Vullo V., Carosi G. e la coorte MASTER. Rischio di epatotossicità in una coorte di 1089 pazienti HIV-HCV co-infetti trattati con HAART: risultati della coorte MASTER-EPOKA-A. XVII Convegno Nazionale AIDS e Sindromi Correlate. Milano, Italy, 28-30 November 2004. Abstract 012.

14. Torti C., Quiros-Roldan E., Moretti F., Ragazzi M., De Luca A., Mazzotta F., Antinori A., Ladina N., Micheli V., Carosi G. The relative prognostic value of adherence and plasma drug concentrations on the virological response after salvage HAART: the RADAR Group of the MASTER Cohort. In: Program and abstract of the: 3th European Drug Resistance Workshop. Athens, Greece, March 30th- April 1st 2005. [abstract 47].

15. Torti C., Quiros-Roldan E., Regazzi M., Antinori A., Moretti F., Cologni G., Zinzi D., Lo Caputo S., Perini P., Carosi G. Factors associated with early virological failure after tenofovir+didanosine+efavirenz combination in naive patients: the KARINA-SISTHER Group of the MASTER Cohort. In: Program and abstract of the: 3th European Drug Resistance Workshop. Athens, Greece, March 30th- April 1st 2005. [abstract 58].

16. Saracino A., Monno L., Scudeller L., Cibelli D., Tartaglia A., Punzi G., Torti C., Lo Caputo S., Mazzotta F., Angarano G. Impact of previously unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non nucleoside inhibitors. In: Program and abstract of the: 3th European Drug Resistance Workshop. Athens, Greece, March 30th- April 1st 2005. [abstract 58].

17. Torti C., Lapadula G., Casari S., Puoti M., Quiros-Roldan E., Bella D., Pastore G., Ladisa N., Minoli L., Sotgiu G., Mazzotta F., Lo Caputo S., Bonora S., Filice G., Carosi G., Liver enzyme elevation after single PI vs. boosted PI vs. NNRTI-based HAART in a cohort of 1,038 HCV/HIC co-infected patients: results of the MASTER-EPOKA-a cohort. In: Program and abstract of the: 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July 24th-27th 2005. [abstract TuPe1.1C14].


18. Torti C., Lapadula G., Puoti M., Casari S., Uccelli M.C., Moretti F., Cologni G., Pastore G., Ladisa N., Minoli L., Sotgiu G., Lo Caputo S., Bonora S., Carosi G. e il gruppo di studio EPOKA-a della coorte MASTER. Influenza della confezione con genotipo 3 di HCV sul rischio di ipertransaminasemia in pazienti HIV-1 positivi in corso di terapia antiretrovirale. Risultati della coorte EPOKA-A MASTER. XIX congresso nazionale AIDS e sindromi correlate. Vibo Valenzia, Italy, 21-23 ottobre 2005 [abstract 10]. 

19. Lapadula G., Torti C., Puoti M., Costarelli S., Tirelli V., Cristini G., Castelnuovo F., Pastore G., Ladisa N., Minoli L., Sotgiu G., Mazzotta F., Bonora S., Carosi G. e il gruppo di studio EPOKA-a della coorte MASTER. Influenza del genotipo di HCV sul rischio di dislipidemia in pazienti HIV-1 positivi in corso di terapia antiretrovirale. Risultati della coorte EPOKA-A MASTER. XIX congresso nazionale AIDS e sindromi correlate. Vibo Valenzia, Italy, 21-23 ottobre 2005 [abstract 11].

20. Torti C., Carosi G. e Centri MASTER data-base. Il Progetto MASTER. XIX congresso nazionale AIDS e sindromi correlate. Vibo Valenzia, Italy, 21-23 ottobre 2005 [abstract 217].

21. Gianotti N., Mondino V., Rossi M.C., Chiesa E., Mezzaroma I., Ladina N., Guaraldi G., Torti C., Falconi Di Francesco L., Castelli P., Di Carlo A., Boeri E., Keulen W., Mc Kenna P., Lazzarin A. Comparison of a rule-based with a phenotype-based algorithm for interpretation of HIV-genotype in guidino salvage regimens in HIV-infected, failing patients, by a randomized clinical trial. 10th European AIDS Conference, Novembre 17-20 2005 [Abstract PE3.4/2]. Dublin (Ireland)

22. Torti C., Quiros-Roldan E., Cologni G., Antinori A., Maccarelli M., Orani A., Perini P., Mazzotta F., Lo Caputo S., Magoni M., Carosi G. Tenofovir+lamivudine+efavirenz versus zidovudine+lamivudine+lopinavir/ritonavir in antiretroviral naive HIV-infected patients: “ad interim” results of a prospective randomized study (SISTHER) of the Italian MASTER Cohort. 10th European AIDS Conference, Novembre 17-20 2005 [Abstract PE7.3/12]. Dublin (Ireland)

23. Antinori A., Trotta M.P., Torti C., Lorenzini P., Maggiolo F., Paraninfo G., Migliorino G., Castelnuovo F., Minoli L., Ladisa N., Antonucci G., Sighinolfi L., Suter F., Carosi G. Response to second-line antiretroviral regimens in patients who started a PI or NNRTI based first line regimen: results from the Italian MASTER database initiative. 10th European AIDS Conference, Novembre 17-20 2005 [Abstract PE7.4/10]. Dublin (Ireland) 

24. Maggiolo F., Arici C., Torti C., Casari S., Antinori A., Antonucci G., Migliorino G., Lo CAputo S., Maserati R., Sighinolfi L., Mondello P., Ladina N., Suter F., Carosi. Use of antiretroviral agents in previously naive HIV infected patients: analysis of a large multicentre cohort (the Italian MASTER database iniziative) 10th European AIDS Conference, Novembre 17-20 2005 [Abstract PE7.9/12]. Dublin (Ireland)

25. Torti C., Uccelli M.C., Quiros-Roldan E., Tirelli V., Regazzi M., Pierotti P., Tinelli C., De Luca A., Patroni A., Moretti F., Carosi G. Prediction of early and confirmed virological response by a genotypic inhibitory quotient for lopinavir in patients with limited exposure to previous protease inhibitors: results from the RADAR study of the MASTER cohort. 10th European AIDS Conference, November 17-20 2005 [Abstract PS6/7]. Dublin (Ireland)

26. Torti C., Puoti M, Lapadula G., Uccelli C., Casari S., Bella D., Pastore G., Minoli L., Lo Caputo S., Bonora S., Bruno R., Carosi G. The influence of genotype 3 hepatitis C co-infection on liver enzyme elevations in HIV-infected patients after commencement of a new HAART: results from the MASTER-EPOKA cohort. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C., December 16-19 2005 [Abstract H-1484].

27. Larder B., Geretti A., Monno L., Torti C., Revell A., Wang D., Harrigan R., Montaner J., Lane H. Neural networks are more accurate predictors of virologic response to antiretroviral therapy than rules based genotype interpretation systems. 13th Conference on Retroviruses and Opportunistic Infections, February 5-8 2006 [Abstract 653]. Denver (CO) USA

28. Lapadula G., Torti C., Cologni G., Castelnuovo F., Moretti F., Costarelli S., Ladisa N., Maserati R., Di Pietro M., Carosi G. Influence of hepatitis C genotypes on lipid elevations in HIV+ patients durino HAART. 13th Conference on Retroviruses and Opportunistic Infections, February 5-8 2006 [Abstract 877]. Denver (CO) USA

29. Antinori A., Trotta M.P., Torti C., Lorenzini P., Maggiolo F., Paraninfo G., Migliorino G., Castelnuovo F., Minoli L., Ladisa N., Antonucci G., Sighinolfi L., Suter F., Carosi G. Sequencing HAART after a PI or NNRTI based first line regimen: results from the Italian MASTER Cohort. 10th International Workshop on HIV Observational Databases, March 23-26, 2006 [Abstract 80]. Madrid (Spain).

30. Torti C., Paraninfo G., Casari S., Quiros-Roldan E., Suter F., Maggiolo F., Quirino T., Migliorino G., Minoli L., Maserati R., Ghinelli F., Sighinolfi L., Mazzotta F., Lo Caputo S., Antinori A., Antonucci F., Pastore G., Ladisa N., Castelnuovo F., Tinelli C., De Silvestri A., Carosi G. Risk of clinical progression over long-term follow-up in a wide cohort of patients by different patterns of viro-immunological response assessed at month 18: Results of the Italian MASTER Cohort. XVI International AIDS Conference, 13-18 August 2006, Toronto, Canada [MOPDB01].

31. Lapadula G., Torti C., Mandalia S., Pozniak A., d’Arminio-Monforte A., Castagna A., Mussini C., Antinori A., Cicconi P., Carosi G., La semplificazione da regimi HAART basati su PI a regimi basati su NNRTI o NRTI è associata a un ridotto recupero immunologico? XX Congresso Nazionale AIDS e Sindromi Correlate, 28-30 Novembre 2006, Roma [Abstract p. 23].

32. Torti C., Cologni G., Quiros-Roldan E., Antinori A., Orani A., Tirelli V., Sosta E., Lapadula G., Costarelli S., Lo Caputo S., Magoni M., Carosi G., SiSTHER Group of the MASTER Cohort. Lopinavir/r+zidovudine+lamivudine versus efavirenz+tenofovir+lamivudine as first-line HAART: a pilot RCT (The Si.S.Ther. trial). 4th IAS Conference on HIV pathogenesis, treatment and prevention. July 22-25, 2007, Sydney, Australia [abstract CDB246].

33. Torti C., Magoni M., Maggiolo F., Mazzotta F., Ladisa N., Maserati R., Migliorino M., Antinori A., De Luca A., D’Arminio-Monforte A., Castelnuovo F., Paraninfo G., Casari S., Carosi G. MASTER-database Cohort. Evolution of exposure and failure to antiretroviral drugs: results from the Italian MASTER database cohort (years 2000-2005). 4th IAS Conference on HIV pathogenesis, treatment and prevention. July 22-25, 2007, Sydney, Australia [abstract CDB259].

34. Lapadula G., Mandalia S., Pozniak A., D’Arminio-Monforte A., Castagna A., Mussini C., Suter F., Quiros-Roldan E., Antinori A., Torti C., and the MASTER, ICONA, Chelsea & Westminster Hospital, HSR and Modena HIV Cohort Collaboration Study Groups. Is simplification from PI-based to NNRTI- or NRTI-based HAART associated with reduced immune recovery?. 11th International Workshop on HIV Observational Databases. Monte Carlo 22-25 March 2007 [Abstract 24]. 

35. De Silvestri A., Paraninfo G., Maserati R., Quirino T., Antinori A., D’Arminio-Monforte A., Suter F., Castelnuovo F., Sighinolfi L., Mazzotta F., Pastore G., De Luca A., Casari S., Lapadula G., Torti C., Carosi G., Tinelli C. Impact of missing data on risk estimates: available-case analysis, multiple imputations and sample selection methods. 11th International Workshop on HIV Observational Databases. Monte Carlo 22-25 March 2007 [Abstract 59]. 

36. Torti C., Cologni G., Quiros-Roldan E., Lapadula G., Pinti M., Cossarizza A., Manca N., Gargiulo F., Costarelli S., Carosi G. Plasma HIV load and proviral DNA response after two standard antiretroviral regimens in HIV positive patients naive to antiretrovirals. 11th European AIDS Conference / EACS. Madrid 24-27 October 2007 [Abstract P1.4/04].

37. Lapadula G., Torti C., Quiros-Roldan E., Costarelli S., Tirelli V., Carosi G. Risk of early virological failure to tenofovir/emtricitabine once daily plus nevirapine twice daily in HIV infected patients naïve to antiretroviral therapy. 11th European AIDS Conference / EACS. Madrid 24-27 October 2007 [Abstract P7.3/10].

38. Castagna A., Galli L., Torti C., D’Arminio-Monforte A., Mussini C., Antinori A., Cozzi-Lepri A., Ladisa N., De Luca A., Lazzarin A., IDD-HSR Cohort, Master Cohort, Icona Cohort, Modena Cohort. 11th European AIDS Conference / EACS. Madrid 24-27 October 2007 [Abstract P7.9/07].

39. Lapadula G., Quiros-Roldan E., Antinori A., Chiesa E., Lo Caputo S., Castelnuovo F., Maggiolo F., De Luca A., Paraninfo G., Antonucci G., Sighinolfi L., Torti C., Carosi G., MASTER Cohort. Hyperbilirubinemia and hypertransaminasemia during treatment with atazanavir: expereince from the Italian MASTER Cohort database. 11th European AIDS Conference / EACS. Madrid 24-27 October 2007 [Abstract P9.6/03].